European Cannabis Market Research Report 2022: Unlicensed Medical Cannabis Sales and Projected Sales of Adult Use Cannabis in Europe

News provided by

Apr 25, 2022, 12:45 ET

DUBLIN, April 25, 2022 /PRNewswire/ -- The "European Cannabis Report with Market Sizing Data & Adult-Use Cannabis Supplement" report has been added to ResearchAndMarkets.com's offering.

2021 was another huge year for the liberalisation and mainstreaming of cannabis in Europe.

Legislation, regulations and market developments continued to evolve for the better. Many countries continued to improve their medical cannabis access schemes, and the publisher estimates that €354 million worth of unlicensed medical cannabis will be sold in Europe in 2022, and this could reach to €2.3 billion in 2026.

CBD products are continuing their path towards recognition as fully-legal consumer packaged goods (CPGs). As of 2022, several novel foods applications for CBD have been validated by the European Commission.

But, the story which is drawing most international attention is the upcoming liberalisation of adult-use cannabis in Europe, with the ruling coalition of Germany promising full legalisation and commercialisation of adult-use cannabis in this legislative term. Legal sales are set to start in Switzerland by the end of 2022 followed shortly by those in the Netherlands.

Key Topics Covered:

Market Sizing

Unlicensed Medical Cannabis Sales in Europe
Projected Sales of Adult Use Cannabis in Europe
CBD Sales in Europe
Country Focus

Expert Interviews

Benedikt Sons, Cansativa Group
Jakob Sons, Cansativa Group
Timo Bongartz, Fluence EMEA
Dr Anne Schlag, Project Twenty21
Bek Muslimov & Nikolay Tretiyakov, Leafy Tunnel
Denise Fatischek, Tilray

CBD

Fragmented European Markets
CBD Legislation in Europe
CBD as a Cosmetic
CBD as a Medicine
Ingestible CBD
CBD Flowers

Trends

Medical Cannabis Pilot Trials
Supply Chain
Product Shortages in Europe
Countries Allowing Cultivation in Europe
Patients and Products
Expert Interviews

Country Focus

Germany
Italy
The Netherlands
Poland
United Kingdom
Switzerland
Czechoslovakia

Companies Mentioned

4C Labs
Brains Bio
Canna-X
Cannabis Europa
Cannavigia
Cansativa Group
Cantourage
CBDepot.eu
Fluence
Linnea
MGC Pharma
Perfect Plants
SOMAI Pharmaceuticals
Storz & Bickel

For more information about this report visit https://www.researchandmarkets.com/r/ctabgo

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets